BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2025 9:22:03 AM | Browse: 85 | Download: 104
 |
Received |
|
2025-04-02 10:41 |
|
Peer-Review Started |
|
2025-04-02 10:41 |
|
First Decision by Editorial Office Director |
|
2025-05-09 13:18 |
|
Return for Revision |
|
2025-05-09 13:18 |
|
Revised |
|
2025-05-17 19:38 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-07-24 02:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-07-24 10:22 |
|
Articles in Press |
|
2025-07-24 10:22 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-03 08:14 |
|
Publish the Manuscript Online |
|
2025-09-25 09:22 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Field of Vision |
| Article Title |
Real-life practice of Kelleni’s protocol in treatment and post exposure prophylaxis of SARS-CoV-2 HV.1 and JN.1 subvariants
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mina Thabet Kelleni |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mina Thabet Kelleni, Assistant Professor, MD, PhD, Department of Pharmacology, College of Medicine, Minia University, Main Road Shalaby Land, Minya 61519, Egypt. mina.kelleni@mu.edu.eg |
| Key Words |
Severe acute respiratory syndrome coronavirus 2; HV.1; JN.1; Post exposure prophylaxis; Kelleni’s protocol; Nitazoxanide; Non-steroidal anti-inflammatory drugs |
| Core Tip |
Coronavirus disease 2019 (COVID-19) has claimed the lives of over seven million people worldwide. Most deaths have occurred among high-risk patients, making it crucial to find a protocol that is effective for post-exposure prophylaxis in this pandemic and future ones. This article provides insight into how Kelleni’s protocol was successfully and safely used to save lives among high-risk groups of COVID-19 patients amidst the ongoing evolution of severe acute respiratory syndrome coronavirus 2. |
| Publish Date |
2025-09-25 09:22 |
| Citation |
Kelleni MT. Real-life practice of Kelleni’s protocol in treatment and post exposure prophylaxis of SARS-CoV-2 HV.1 and JN.1 subvariants. World J Virol 2025; 14(3): 107903 |
| URL |
https://www.wjgnet.com/2220-3249/full/v14/i3/107903.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v14.i3.107903 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
